webinar: srp-9001 data update from studies 101, 102, and 103 (august 2022)

Published 2 years ago • 2K plays • Length 1:06:22

Download video MP4
Download video MP3

Similar videos

1:05:59

webinar: srp-9001 micro-dystrophin gene therapy clinical update (june 2021)
1:09:52

webinar: srp-9001 micro-dystrophin gene therapy clinical update (october 2021)
1:24:49

webinar: srp-9001 gene therapy path forward (november 2020)
46:01

webinar: envision study update with sarepta therapeutics
1:41

clinical trial: srp-9001 for duchenne muscular dystrophy (nct03769116)
1:01:36

[webinar] introducing ppmo – sarepta therapeutics – may 2018
46:07

webinar: casimir's duchenne video assessment (dva) arise study [august 2022]
54:57

gene therapy: the power of advocacy & real world evidence -- ppmd 2023 annual conference
18:41

in the pipeline: gene therapy - sarepta therapeutics
1:42

sarepta's srp-9001, gene therapy, for duchenne muscular dystrophy faces fda decision delay
12:11

sarepta's srp-9001 gene therapy for duchenne muscular dystrophy faces fda advisory committee review
1:30:40

gene therapy approaches to replace or restore dystrophin -- ppmd 2022 annual conference
1:35

updates on a trial of srp-9001 gene transfer therapy in duchenne muscular dystrophy (dmd)
1:16

sarepta' srp-9001, gene therapy to treat duchenne muscular dystrophy gets fda ad comm recommendation

Clip.africa.com - Privacy-policy